Beyond Genomics Announces Research And Development Advisory Board Lead By Co-Chairs Arnold Levine, PhD And Jeffrey Friedman, MD, Ph.D  
10/19/2005 5:08:58 PM

Beyond Genomics, Inc. today announced the formation of a Research and Development Advisory Board comprised of leading scientists with broad experience in the study of human disease, and the discovery and development of pharmaceutical products. Arnold Levine, PhD and Jeffrey Friedman, MD, PhD are co-chairs of the board. The company expects the Advisory Board to make active recommendations for the use of Beyond Genomics' proprietary Molecular Systems Biology platforms both for internal drug development programs and in research alliances with pharmaceutical company partners. The other members of the Advisory Board are: David Jackson, PhD; Jan van der Greef, PhD; Victor Dzau, MD; Marc Kirschner, PhD; Douglas Lauffenburger, PhD; and Christopher Sander, PhD.